Targeting peroxisome proliferator-activated receptor-gamma in peritoneal dialysis patients - Will it reduce inflammation, atherosclerosis, calcification and improve survival of peritoneal dialysis patients?
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 07 Jul 2010 Biomarkers information updated
- 29 Aug 2007 New trial record.